Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds

Zhiwei Wang,* Ming Li,* Baoqing Yu, Liehu Cao, Qingsong Yang, Jiacan SuDepartment of Orthopedics, Shanghai Hospital, Second Military Medical University, Shanghai, People's Republic of China *These authors contributed equally to this workAbstract: A bioactive composite of nano calcium-def...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang Z, Li M, Yu B, Cao L, Yang Q, Su J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/e90a839485104a8e92a076fd16fbf029
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e90a839485104a8e92a076fd16fbf029
record_format dspace
spelling oai:doaj.org-article:e90a839485104a8e92a076fd16fbf0292021-12-02T06:31:45ZNanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds1176-91141178-2013https://doaj.org/article/e90a839485104a8e92a076fd16fbf0292012-07-01T00:00:00Zhttp://www.dovepress.com/nanocalcium-deficient-hydroxyapatitendashpoly-epsilon-caprolactonendas-a10350https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Zhiwei Wang,* Ming Li,* Baoqing Yu, Liehu Cao, Qingsong Yang, Jiacan SuDepartment of Orthopedics, Shanghai Hospital, Second Military Medical University, Shanghai, People's Republic of China *These authors contributed equally to this workAbstract: A bioactive composite of nano calcium-deficient apatite (n-CDAP) with an atom molar ratio of calcium to phosphate (Ca/P) of 1.50 and poly(ε-caprolactone)–poly(ethylene glycol)–poly(ε-caprolactone) (PCL–PEG–PCL) was synthesized, and a composite scaffold was fabricated. The composite scaffolds with 40 wt% n-CDAP contained well interconnected macropores around 400 µm, and exhibited a porosity of 75%. The weight-loss ratio of the n-CDAP/PCL–PEG–PCL was significantly greater than nano hydroxyapatite (n-HA, Ca/P = 1.67)/PCL–PEG–PCL composite scaffolds during soaking into phosphate-buffered saline (pH 7.4) for 70 days, indicating that n-CDAP-based composite had good degradability compared with n-HA. The viability ratio of MG-63 cells was significantly higher on n-CDAP than n-HA-based composite scaffolds at 3 and 5 days. In addition, the alkaline phosphatase activity of the MG-63 cells cultured on n-CDAP was higher than n-HA-based composite scaffolds at 7 days. Histological evaluation showed that the introduction of n-CDAP into PCL–PEG–PCL enhanced the efficiency of new bone formation when the composite scaffolds were implanted into rabbit bone defects. The results suggested that the n-CDAP-based composite exhibits good biocompatibility, biodegradation, and osteogenesis in vivo.Keywords: nano calcium-deficient apatite, composite scaffold, degradability, cell responses, osteogenesisWang ZLi MYu BCao LYang QSu JDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 3123-3131 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Wang Z
Li M
Yu B
Cao L
Yang Q
Su J
Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
description Zhiwei Wang,* Ming Li,* Baoqing Yu, Liehu Cao, Qingsong Yang, Jiacan SuDepartment of Orthopedics, Shanghai Hospital, Second Military Medical University, Shanghai, People's Republic of China *These authors contributed equally to this workAbstract: A bioactive composite of nano calcium-deficient apatite (n-CDAP) with an atom molar ratio of calcium to phosphate (Ca/P) of 1.50 and poly(ε-caprolactone)–poly(ethylene glycol)–poly(ε-caprolactone) (PCL–PEG–PCL) was synthesized, and a composite scaffold was fabricated. The composite scaffolds with 40 wt% n-CDAP contained well interconnected macropores around 400 µm, and exhibited a porosity of 75%. The weight-loss ratio of the n-CDAP/PCL–PEG–PCL was significantly greater than nano hydroxyapatite (n-HA, Ca/P = 1.67)/PCL–PEG–PCL composite scaffolds during soaking into phosphate-buffered saline (pH 7.4) for 70 days, indicating that n-CDAP-based composite had good degradability compared with n-HA. The viability ratio of MG-63 cells was significantly higher on n-CDAP than n-HA-based composite scaffolds at 3 and 5 days. In addition, the alkaline phosphatase activity of the MG-63 cells cultured on n-CDAP was higher than n-HA-based composite scaffolds at 7 days. Histological evaluation showed that the introduction of n-CDAP into PCL–PEG–PCL enhanced the efficiency of new bone formation when the composite scaffolds were implanted into rabbit bone defects. The results suggested that the n-CDAP-based composite exhibits good biocompatibility, biodegradation, and osteogenesis in vivo.Keywords: nano calcium-deficient apatite, composite scaffold, degradability, cell responses, osteogenesis
format article
author Wang Z
Li M
Yu B
Cao L
Yang Q
Su J
author_facet Wang Z
Li M
Yu B
Cao L
Yang Q
Su J
author_sort Wang Z
title Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
title_short Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
title_full Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
title_fullStr Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
title_full_unstemmed Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
title_sort nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/e90a839485104a8e92a076fd16fbf029
work_keys_str_mv AT wangz nanocalciumdeficienthydroxyapatiteampndashpolyampepsiloncaprolactoneampndashpolyethyleneglycolampndashpolyampepsiloncaprolactonecompositescaffolds
AT lim nanocalciumdeficienthydroxyapatiteampndashpolyampepsiloncaprolactoneampndashpolyethyleneglycolampndashpolyampepsiloncaprolactonecompositescaffolds
AT yub nanocalciumdeficienthydroxyapatiteampndashpolyampepsiloncaprolactoneampndashpolyethyleneglycolampndashpolyampepsiloncaprolactonecompositescaffolds
AT caol nanocalciumdeficienthydroxyapatiteampndashpolyampepsiloncaprolactoneampndashpolyethyleneglycolampndashpolyampepsiloncaprolactonecompositescaffolds
AT yangq nanocalciumdeficienthydroxyapatiteampndashpolyampepsiloncaprolactoneampndashpolyethyleneglycolampndashpolyampepsiloncaprolactonecompositescaffolds
AT suj nanocalciumdeficienthydroxyapatiteampndashpolyampepsiloncaprolactoneampndashpolyethyleneglycolampndashpolyampepsiloncaprolactonecompositescaffolds
_version_ 1718399908208181248